MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Association of Liver Fibrosis with Motor Deficits in Parkinson’s Disease

    A. Zolin, H. Ooi, H. Sarva (New York, USA)

    Objective: To determine the impact of liver fibrosis on motor symptoms in Parkinson’s disease Background: Parkinson’s disease motor symptoms can vary with systemic illnesses [1,2].…
  • 2024 International Congress

    Imaging the Nigrostriatal Pathway in Patients with Idiopathic Normal Pressure Hydrocephalus and Parkinsonism

    G. Palermo, A. Francesconi, G. Bellini, R. Morganti, G. Migaleddu, D. Di Carlo, P. Perrini, N. Benedetto, C. Pacchetti, D. Volterrani, M. Cosottini, R. Ceravolo (Pisa, Italy)

    Objective: To investigate the nigrostriatal pathway in iNPH patients with clinical parkinsonism, employing dopaminergic transporter (DAT) and nigrosome imaging. Background: Patients with idiopathic Normal Pressure…
  • 2024 International Congress

    Decoding non-IPD Parkinsonism – A Comparative Analysis of Atypical and Secondary Parkinsonism

    M. Acharya (Kharagpur, India)

    Objective: Using precise diagnostic criteria, the single-center observational study aims to evaluate the clinical profiles of non-IPD parkinsonism, specifically identifying crucial clinical clues for discriminating…
  • 2024 International Congress

    Perry Syndrome due to a DCTN1 novel variant

    P. Lorenzo-Barreto, I. Muro-García, E. Casas-Peña, JP. Romero-Muñoz, L. López-Manzanares (Madrid, Spain)

    Objective: To report the clinical features of a patient with Perry syndrome (PS) due to a heterozygous novel pathogenic variant in the DCTN1 gene. Background:…
  • 2024 International Congress

    Immunomodulatory Effects Of Covid-19 Vaccination On Inflammatory And Neurotrophic Factors In Parkinson’s Disease: Insights From Clinical Subtypes

    J. Salimjonov, N. Rashidova, KH. Khalimova, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: This study investigates the impact of COVID-19 vaccination on levels of interleukin 6 (IL-6) and brain-derived neurotrophic factor (BDNF) in patients with Parkinson's disease…
  • 2024 International Congress

    The course of cognitive impairment in Parkinson’s disease patients with Сovid-19

    R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: A comparative analysis of the characteristics of cognitive impairment in Parkinson's disease patients with and without Сovid-19. Background: Covid-19 infection strongly affects the central…
  • 2024 International Congress

    Incidence and Prevalence of Parkinson’s Disease Among United States Medicare Beneficiaries by Age, Sex, Race/Ethnicity, and Neighborhood Socioeconomic Status 2014-2021

    T. Rosa, S. Mantri, C. Ford, S. Soneji, B. Kaufman, F. Li, B. Grory, Y. Xian, K. Johnson, R. O’Brien, E. O’Brien, J. Lusk, B. Hammill (Durham, USA)

    Objective: To evaluate the trends and differences in incidence and prevalence of Parkison's disease (PD) in Medicare beneficiaries between 2014-2021 across different demographics. Background: The…
  • 2024 International Congress

    Effect of various mGlu2 and mGlu2/3 activators on parkinsonism: a sub-analysis in the MPTP-lesioned primate

    W. Kang, I. Frouni, S. Nuara, C. Kwan, J. Gourdon, D. Bédard, P. Huot (Montreal, Canada)

    Objective: To evaluate the effect of the metabotropic glutamate 2/3 (mGlu2/3) orthosteric activators (OAs) LY-354,740 and LY-404,039, as well as the effects of the metabotropic…
  • 2024 International Congress

    Cerebral metabolic network in PLA2G6-associated parkinsonism

    XY. Zhou, J. Wang, C. Chen, FT. Liu, CT. Zuo, JJ. Wu, YM. Sun, J. Wang (Shanghai, China)

    Objective: To characterize the cerebral metabolic network in PLA2G6-associated parkinsonism (PLA2G6-P). Background: PLA2G6-associated neurodegeneration is known as a continuum of phenotypes. Patients with late-onset PLA2G6-associated…
  • 2024 International Congress

    Rapidly Progressive Pallidopyramidal Syndrome related to Parkin gene mutation

    F. Mustafa, A. Elavarasi, D. Vibha, R. Singh, J. Parihar, M. Tripathi, A. Das (Calicut, India)

    Objective: To describe a case of rapidly progressive Pallidopyramidal syndrome related to Parkin gene mutation. Background: Parkin gene mutations are most commonly found in autosomal…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley